These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30387924)

  • 1. Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
    Börjesson C; Guinard E; Tauber M; Konstantinou MP; Livideanu CB; Mazereeuw-Hautier J; Meyer N; Paul C
    Dermatol Ther; 2019 Jan; 32(1):e12780. PubMed ID: 30387924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Novel Topical Liposomal Formulation of Cyclosporine in Mild to Moderate Stable Plaque Psoriasis: A Randomized Clinical Trial.
    Kumar R; Dogra S; Amarji B; Singh B; Kumar S; Sharma ; Vinay K; Mahajan R; Katare OP
    JAMA Dermatol; 2016 Jul; 152(7):807-15. PubMed ID: 27096709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
    Bergstrom KG; Arambula K; Kimball AB
    Cutis; 2003 Nov; 72(5):407-11. PubMed ID: 14655784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of cyclosporine versus methotrexate in severe psoriasis: a study from north India.
    Sandhu K; Kaur I; Kumar B; Saraswat A
    J Dermatol; 2003 Jun; 30(6):458-63. PubMed ID: 12810993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.
    Yao DN; Lu CJ; Wen ZH; Yan YH; Xuan ML; Li XY; Li G; He ZH; Xie XL; Deng JW; Guo XF; Ou AH
    Trials; 2016 Mar; 17(1):140. PubMed ID: 26983642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the use of drugs in patients suffering from psoriasis and their impact on quality of life.
    Karamata VV; Gandhi AM; Patel PP; Sutaria A; Desai MK
    Indian J Pharmacol; 2017; 49(1):84-88. PubMed ID: 28458428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris.
    Lu L; Xuan M; Yan Y; Li G; Zhou L; Wen Z; Lu C
    Trials; 2016 Oct; 17(1):482. PubMed ID: 27716422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial.
    Liu M; Li X; Chen XY; Xue F; Zheng J
    Dermatol Ther; 2015; 28(6):373-82. PubMed ID: 26286610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
    J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.
    Thaçi D; Bräutigam M; Kaufmann R; Weidinger G; Paul C; Christophers E
    Dermatology; 2002; 205(4):383-8. PubMed ID: 12444336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
    Short MW; Vaughan TK
    Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis.
    Lowe N; Feldman SR; Sherer D; Weiss J; Shavin JS; Lin YL; Foley V; Soto P
    J Dermatolog Treat; 2005 Aug; 16(3):158-64. PubMed ID: 16096182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy.
    Bagel J; Zapata J; Nelson E
    J Drugs Dermatol; 2018 Aug; 17(8):845-850. PubMed ID: 30124723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I randomized trial to assess the effect on skin infiltrate thickness and tolerability of topical phosphodiesterase inhibitors in the treatment of psoriasis vulgaris using a modified psoriasis plaque test.
    Snape SD; Wigger-Alberti W; Goehring UM
    Br J Dermatol; 2016 Sep; 175(3):479-86. PubMed ID: 27038440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization, and
    Walunj M; Doppalapudi S; Bulbake U; Khan W
    J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
    Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus.
    Chiricozzi A; Pimpinelli N; Ricceri F; Bagnoni G; Bartoli L; Bellini M; Brandini L; Caproni M; Castelli A; Fimiani M; Marsili F; Mazzatenta C; Niccoli MC; Panduri S; Pellegrino M; Sirna R; Volpi W; Romanelli M; Prignano F
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28940579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis.
    Decroix J; Pres H; Tsankov N; Poncet M; Arsonnaud S
    Cutis; 2004 Sep; 74(3):201-6. PubMed ID: 15499763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
    Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
    Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.